Zimmer Biomet to Showcase Complete Shoulder Solution Designed to Support Surgeon Flexibility 

(WARSAW, Ind.) Sept. 18, 2026 — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced it will showcase its Complete Shoulder Solutions at the 16th International Congress of Shoulder and Elbow Surgery (ICSES 2026).

Every shoulder case may bring its own clinical considerations. Zimmer Biomet’s shoulder technologies are designed to give those surgeons the flexibility to select an approach that fits the patient, procedure and care setting.

Zimmer Biomet will showcase robotic-assisted surgery, mixed reality navigation, pre-operative planning software, implant systems for anatomic and reverse arthroplasty and sports medicine technologies, including biologics.

The updated ROSA^® Shoulder System, which received expanded U.S. FDA 510(k) clearance in May 2026 is the industry’s first robotic system to support both glenoid and humeral preparation for anatomic and reverse total shoulder arthroplasty techniques.¹^-2

The system adds improved robotically assisted glenoid reaming and humeral resection capabilities, building on the existing ROSA Shoulder platform. It uses digital tools to navigate patient anatomy and cross-validate findings to help reduce reliance on manual estimation. The system’s data also integrates with the mymobility^® Care Management Platform to leverage pre-, intra- and post-operative data. The goal is to provide surgeons with data they can use to inform decisions throughout the patient journey, supporting a more personalized and measurable approach to care.

“The foundation of the ROSA Shoulder System is grounded in real-world surgeon insights,” said Brian Hatcher, President, Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Thoracic. “We partnered closely with leading shoulder surgeons, listening to their experiences in the operating room to understand exactly what they need in the moments that matter: visibility, precision, efficiency and flexibility.”

Also on display at ICSES is Signature Vision™, a compact, surgeon-centric mixed reality system designed to deliver real-time holographic feedback on instrument positioning relative to the surgical plan. It can also fit into smaller surgical environments without rearranging staff flow or setup. Navigation lives in the surgeon’s line of sight rather than on a separate screen. The system is compatible with a broad implant portfolio; Signature Vision extends confidence through technology designed to work with implants surgeons know and trust.

“As shoulder arthroplasty volumes continue to grow, we want to make sure surgeons have more than one way to close the gap between what they plan and what they deliver,” said Hatcher. “This year’s ICSES exhibit reflects Zimmer Biomet’s commitment to delivering a complete shoulder solution approach from innovative pre-operative planning and robotic technologies to soft tissue repair and total shoulder arthroplasty.”

Products and technologies on display at [Booth 404] will include:

Robotics and Navigation

• The ROSA^® Shoulder System — robotically assisted total shoulder arthroplasty for anatomic and reverse procedures with expanded glenoid reaming and humeral resection capabilities
• Signature Vision™ — compact mixed reality navigation delivering real-time holographic guidance for shoulder arthroplasty (in surgeon evaluation)

Upper Extremities

• Identity^® Shoulder System — dynamic platform system designed to enable the surgeon to tailor the construct to the patient in front of them in anatomic, reverse and revision cases.
• Comprehensive^® Shoulder System — including Augmented Baseplates, Vault Reconstruction System (VRS™) and Segmental Revision System (SRS); the Comprehensive Reverse has the highest long-term survivorship rate of any reverse shoulder system in the AOANJRR registry. In its 2025 Annual Report, the AOANJRR showed Comprehensive Reverse had a 10-year survivorship rate of 96.6%.⁴
• OsseoFit^® Stemless Shoulder System — bone-preserving implant designed to match the asymmetric humeral anatomy,^3-5 optimizing fit with left- and right-side options in five sizes for anatomic shoulder arthroplasty
• Signature™ ONE Planner – 3D CT-based planning software designed to streamline pre-operative workflows with simulated join assessments and efficient case plan turnaround times⁶

Sports Medicine

• OsseoCoat™ JuggerKnot^® Soft Anchor System, Tapestry^® Biointegrative Implant, ActivBraid^® Collagen-UHMWPE Suture and Genie™ Knotless Anchors — all part of the ZB-3™ Biologic Continuum for rotator cuff repair, spanning anchor, suture and biologic technologies

About Zimmer Biomet

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation. 

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X at www.x.com/zimmerbiomet.
 

Signature Vision Legal Manufacturer: MR Surgical Solutions, LLC, Bubenbergstrasse 1, 3rd Floor, 8045 Zurich – CH

Cautionary Statement Regarding Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet’s expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially. For a list and description of some of such risks and uncertainties, see Zimmer Biomet’s periodic reports filed with the U.S. Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Zimmer Biomet’s filings with the SEC. Forward-looking statements speak only as of the date they are made, and Zimmer Biomet disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.